Literature DB >> 25752193

Selected ginsenosides of the protopanaxdiol series are novel positive allosteric modulators of P2X7 receptors.

R M Helliwell1, C O ShioukHuey2, K Dhuna2, J C Molero1, J-M Ye1, C C Xue1, L Stokes2,3.   

Abstract

BACKGROUND AND
PURPOSE: The P2X7 receptor is an ATP-gated ion channel predominantly expressed in immune cells and plays a key role in inflammatory processes. Ginseng is a well-known Chinese herb with both pro- and anti-inflammatory properties and many of its actions have been ascribed to constituent ginsenosides. We screened a number of ginsenoside compounds for pharmacological activity at P2X7 receptors, that might contribute to the reported immunomodulatory actions of ginseng. EXPERIMENTAL APPROACH: We used several assays to measure responses of P2X7 receptors, ATP-mediated dye uptake, intracellular calcium measurement and whole-cell patch-clamp recordings. HEK-293 cells stably expressing human P2X7 receptors were used in addition to mouse macrophages endogenously expressing P2X7 receptors. KEY
RESULTS: Four ginsenosides of the protopanaxdiol series, Rb1, Rh2, Rd and the metabolite compound K (CK) potentiated the dye uptake responses of P2X7 receptors, whereas other ginsenosides tested were ineffective (1-10 μM). The potentiation was rapid in onset, required a threshold concentration of ATP (>50 μM) and had an EC50 of 1.08 μM. CK markedly enhanced ATP-activated P2X7 currents, probably via an extracellular site of action. One of the consequences of this potentiation effect is a sustained rise in intracellular Ca(2+) that could account for the decrease in cell viability in mouse macrophages after a combination of 500 μM ATP and 10 μM CK that are non-toxic when applied alone. CONCLUSIONS AND IMPLICATIONS: This study identifies selected ginsenosides as novel potent allosteric modulators of P2X7 channels that may account for some of the reported immune modulatory actions of protopanaxdiol ginsenosides in vivo.
© 2015 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25752193      PMCID: PMC4500369          DOI: 10.1111/bph.13123

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  49 in total

1.  Pseudoapoptosis induced by brief activation of ATP-gated P2X7 receptors.

Authors:  Amanda B Mackenzie; Mark T Young; Elena Adinolfi; Annmarie Surprenant
Journal:  J Biol Chem       Date:  2005-06-30       Impact factor: 5.157

2.  20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K/Akt signaling pathway.

Authors:  Yun-Long Zhang; Rui Zhang; Hua-Li Xu; Xiao-Feng Yu; Shao-Chun Qu; Da-Yuan Sui
Journal:  Am J Chin Med       Date:  2013       Impact factor: 4.667

3.  Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia.

Authors:  Z J Song; H K Johansen; V Faber; N Høiby
Journal:  APMIS       Date:  1997-06       Impact factor: 3.205

4.  The Rb1 fraction of ginseng elicits a balanced Th1 and Th2 immune response.

Authors:  E Rivera; F Ekholm Pettersson; M Inganäs; S Paulie; K-O Grönvik
Journal:  Vaccine       Date:  2005-11-16       Impact factor: 3.641

5.  Transient P2X7 receptor activation triggers macrophage death independent of Toll-like receptors 2 and 4, caspase-1, and pannexin-1 proteins.

Authors:  Peter J Hanley; Moritz Kronlage; Carsten Kirschning; Adriana del Rey; Francesco Di Virgilio; Jens Leipziger; Iain P Chessell; Sarah Sargin; Mikhail A Filippov; Otto Lindemann; Simon Mohr; Volker Königs; Hermann Schillers; Martin Bähler; Albrecht Schwab
Journal:  J Biol Chem       Date:  2012-01-10       Impact factor: 5.157

6.  Transient receptor potential vanilloid-1 participates in the inhibitory effect of ginsenoside Rg1 on capsaicin-induced interleukin-8 and prostaglandin E2 production in HaCaT cells.

Authors:  Jin Huang; Li Ding; Duo Shi; Jin-Hong Hu; Quan-Gang Zhu; Shen Gao; Lei Qiu
Journal:  J Pharm Pharmacol       Date:  2011-11-10       Impact factor: 3.765

7.  The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner.

Authors:  Linda Tomasinsig; Cinzia Pizzirani; Barbara Skerlavaj; Patrizia Pellegatti; Sara Gulinelli; Alessandro Tossi; Francesco Di Virgilio; Margherita Zanetti
Journal:  J Biol Chem       Date:  2008-09-02       Impact factor: 5.157

8.  Probenecid blocks human P2X7 receptor-induced dye uptake via a pannexin-1 independent mechanism.

Authors:  Archana Bhaskaracharya; Phuong Dao-Ung; Iman Jalilian; Mari Spildrejorde; Kristen K Skarratt; Stephen J Fuller; Ronald Sluyter; Leanne Stokes
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

9.  The Concise Guide to PHARMACOLOGY 2013/14: ion channels.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; William A Catterall; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

10.  Effects of Ginsenoside Metabolites on GABAA Receptor-Mediated Ion Currents.

Authors:  Byung-Hwan Lee; Sun-Hye Choi; Tae-Joon Shin; Sung-Hee Hwang; Jiyeon Kang; Hyeon-Joong Kim; Byung-Ju Kim; Seung-Yeol Nah
Journal:  J Ginseng Res       Date:  2012-01       Impact factor: 6.060

View more
  13 in total

Review 1.  Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery.

Authors:  Chun-Yan Shen; Jian-Guo Jiang; Li Yang; Da-Wei Wang; Wei Zhu
Journal:  Br J Pharmacol       Date:  2016-10-29       Impact factor: 8.739

Review 2.  The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target.

Authors:  Reece Andrew Sophocleous; Lezanne Ooi; Ronald Sluyter
Journal:  Int J Mol Sci       Date:  2022-05-20       Impact factor: 6.208

3.  Synthesis and Structure-Activity Relationship of Pyxinol Derivatives as Novel Anti-Inflammatory Agents.

Authors:  Yixiao Sun; Xiaojuan Fang; Meng Gao; Conghui Wang; Hongyan Gao; Wenjing Bi; Hanhan Tang; Yetong Cui; Leiming Zhang; Huaying Fan; Hui Yu; Gangqiang Yang
Journal:  ACS Med Chem Lett       Date:  2020-02-12       Impact factor: 4.345

Review 4.  To Inhibit or Enhance? Is There a Benefit to Positive Allosteric Modulation of P2X Receptors?

Authors:  Leanne Stokes; Stefan Bidula; Lučka Bibič; Elizabeth Allum
Journal:  Front Pharmacol       Date:  2020-05-12       Impact factor: 5.810

5.  P2X7 Receptors as a Therapeutic Target in Cerebrovascular Diseases.

Authors:  Abraham J Cisneros-Mejorado; Alberto Pérez-Samartín; María Domercq; Rogelio O Arellano; Miroslav Gottlieb; Friedrich Koch-Nolte; Carlos Matute
Journal:  Front Mol Neurosci       Date:  2020-06-18       Impact factor: 5.639

6.  Ginsenosides Act As Positive Modulators of P2X4 Receptors.

Authors:  Kshitija Dhuna; Matthew Felgate; Stefan M Bidula; Samuel Walpole; Lucka Bibic; Brett A Cromer; Jesus Angulo; Julie Sanderson; Martin J Stebbing; Leanne Stokes
Journal:  Mol Pharmacol       Date:  2018-12-13       Impact factor: 4.436

7.  Development of High-Throughput Fluorescent-Based Screens to Accelerate Discovery of P2X Inhibitors from Animal Venoms.

Authors:  Lucka Bibic; Volker Herzig; Glenn F King; Leanne Stokes
Journal:  J Nat Prod       Date:  2019-09-18       Impact factor: 4.050

Review 8.  Structural and Functional Basis for Understanding the Biological Significance of P2X7 Receptor.

Authors:  María Ángeles Martínez-Cuesta; María Amparo Blanch-Ruiz; Raquel Ortega-Luna; Ainhoa Sánchez-López; Ángeles Álvarez
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

9.  N-Alkyl-Substituted Isatins Enhance P2X7 Receptor-Induced Interleukin-1β Release from Murine Macrophages.

Authors:  Ronald Sluyter; Kara L Vine
Journal:  Mediators Inflamm       Date:  2016-07-21       Impact factor: 4.711

10.  Astragaloside IV protects rat retinal capillary endothelial cells against high glucose-induced oxidative injury.

Authors:  Yuan Qiao; Chun-Lan Fan; Min-Ke Tang
Journal:  Drug Des Devel Ther       Date:  2017-12-13       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.